These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


403 related items for PubMed ID: 22137743

  • 1. Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study.
    Naganuma M, Shiga T, Sato K, Murasaki K, Hashiguchi M, Mochizuki M, Hagiwara N.
    Thromb Res; 2012 Jul; 130(1):21-6. PubMed ID: 22137743
    [Abstract] [Full Text] [Related]

  • 2. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 3. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY.
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [Abstract] [Full Text] [Related]

  • 4. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K, Sato M, Goto M, Saito A, Ikeda Y, Fujita S, Fuse K, Takahashi M, Oguro T, Matsushita H, Kitazawa H, Okabe M, Abe H, Toba K, Yamashina A, Aizawa Y.
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [Abstract] [Full Text] [Related]

  • 5. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.
    J Am Coll Cardiol; 2013 Dec 10; 62(23):2199-204. PubMed ID: 24055744
    [Abstract] [Full Text] [Related]

  • 6. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
    Lip GY, Frison L, Halperin JL, Lane DA.
    J Am Coll Cardiol; 2011 Jan 11; 57(2):173-80. PubMed ID: 21111555
    [Abstract] [Full Text] [Related]

  • 7. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S, Bennett D, Smith DJ.
    Am J Cardiovasc Drugs; 2010 Jan 11; 10(1):37-48. PubMed ID: 20104933
    [Abstract] [Full Text] [Related]

  • 8. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH, Park JS, Park JH, Park JS, Kwak JJ, Hwang ES, Kim SK, Choi DH, Kim YH, Pak HN.
    J Cardiovasc Electrophysiol; 2010 May 11; 21(5):501-7. PubMed ID: 20021521
    [Abstract] [Full Text] [Related]

  • 9. Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score.
    Poli D, Antonucci E, Marcucci R, Fatini C, Alterini B, Mannini L, Falciani M, Abbate R, Gensini GF, Prisco D.
    Thromb Res; 2007 May 11; 121(3):347-52. PubMed ID: 17597186
    [Abstract] [Full Text] [Related]

  • 10. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F, Pignatelli P, Malato A, Poli D, Di Minno MN, Di Gennaro L, Rancan E, Pastori D, Grifoni E, Squizzato A, Siragusa S, Di Minno G, Ageno W.
    Am J Hematol; 2012 Apr 11; 87(4):384-7. PubMed ID: 22367852
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L, Rosenqvist M, Lip GY.
    Eur Heart J; 2012 Jun 11; 33(12):1500-10. PubMed ID: 22246443
    [Abstract] [Full Text] [Related]

  • 12. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ, Karim S, Ackroyd-Stolarz S, Fry A, Murphy NG, Christie R, Zed PJ.
    Ann Pharmacother; 2011 Jul 11; 45(7-8):881-7. PubMed ID: 21750309
    [Abstract] [Full Text] [Related]

  • 13. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE.
    N Engl J Med; 2003 Sep 11; 349(11):1019-26. PubMed ID: 12968085
    [Abstract] [Full Text] [Related]

  • 14. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
    Abdelhafiz AH, Wheeldon NM.
    Clin Ther; 2004 Sep 11; 26(9):1470-8. PubMed ID: 15531009
    [Abstract] [Full Text] [Related]

  • 15. Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.
    Boccuzzi SJ, Martin J, Stephenson J, Kreilick C, Fernandes J, Beaulieu J, Hauch O, Kim J.
    Curr Med Res Opin; 2009 Dec 11; 25(12):2853-64. PubMed ID: 19916729
    [Abstract] [Full Text] [Related]

  • 16. Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population.
    Currie CJ, McEwan P, Emmas C, Morgan CL, Peters JR.
    Curr Med Res Opin; 2005 Dec 11; 21(12):1905-13. PubMed ID: 16368039
    [Abstract] [Full Text] [Related]

  • 17. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.
    Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S.
    Circulation; 2007 May 29; 115(21):2689-96. PubMed ID: 17515465
    [Abstract] [Full Text] [Related]

  • 18. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD, Arneklev K, Goldhaber SZ, Spandorfer J, Halperin F, Horrow J.
    Arch Intern Med; 2006 Apr 24; 166(8):853-9. PubMed ID: 16636210
    [Abstract] [Full Text] [Related]

  • 19. The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients.
    Poli D, Antonucci E, Marcucci R, Mannini L, Falciani M, Abbate R, Gensini GF, Prisco D.
    Int J Cardiol; 2009 Feb 06; 132(1):109-13. PubMed ID: 18180057
    [Abstract] [Full Text] [Related]

  • 20. Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
    Lopes RD, Alexander JH, Al-Khatib SM, Ansell J, Diaz R, Easton JD, Gersh BJ, Granger CB, Hanna M, Horowitz J, Hylek EM, McMurray JJ, Verheugt FW, Wallentin L, ARISTOTLE Investigators.
    Am Heart J; 2010 Mar 06; 159(3):331-9. PubMed ID: 20211292
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.